A RETROSPECTIVE SINGLE-CENTER STUDY OF THE OUTCOME OF 5 DIFFERENT THERAPY APPROACHES IN 48 PATIENTS WITH RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Ah. Elmaagacli et al., A RETROSPECTIVE SINGLE-CENTER STUDY OF THE OUTCOME OF 5 DIFFERENT THERAPY APPROACHES IN 48 PATIENTS WITH RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(12), 1997, pp. 1045-1055
In a retrospective single centre study we examined the outcome of five
different therapy approaches in 48 patients in whom a relapse of CML
(13 cytogenetic relapses, 35 hematological relapses: 10 chronic phase
(CP), nine accelerated phase, 16 blast crisis) occurred after allogene
ic BMT, Cyclosporin A (CsA) withdrawal, interferon alpha-2b (IFN-alpha
) therapy, donor leukocyte transfusions (DLT), second transplantation
(2nd BMT), and chemotherapy (CTX) alone were used and studied for thei
r response rates, Patients who achieved a complete hematologic and cyt
ogenetic remission (CR) were studied for BCR-ABL transcripts and for t
heir chimerism status by PCR, A strong antileukemic effect was observe
d after abrupt CsA withdrawal, with 10 of 20 patients achieving a CR (
50%), All 10 patients with early stage (nine cytogenetic and one CP),
but none of the patients with advanced disease recurrence, responded t
o CsA withdrawal, IFN-alpha induced in five of 11 patients (45%) a sta
ble cytogenetic remission, whereas treatment with DLT induced a CR in
only two of 14 patients (14%), A second transplant was performed in si
x patients, Three of six patients (50%) survive disease-free at a medi
an of 19 months after the 2nd BMT (range 10-25), The use of CTX alone
did not induce a remission.